These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9950900)

  • 41. The significance of EMAP-II after allogeneic stem cell transplantation.
    Nomura S; Ishii K; Shimizu M; Inami N; Uoshima N; Urase F; Maeda Y; Hayashi K
    Transpl Immunol; 2009 May; 21(1):23-6. PubMed ID: 19565673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell-surface associated p43/endothelial-monocyte-activating-polypeptide-II in hepatocellular carcinoma cells induces apoptosis in T-lymphocytes.
    Faisal W; Symonds P; Panjwani S; Heng Y; Murray JC
    Asian J Surg; 2007 Jan; 30(1):13-22. PubMed ID: 17337366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of endothelial monocyte activating polypeptide II in tumor necrosis factor-alpha-based anti-cancer therapy.
    Lans TE; Van Horssen R; Eggermont AM; Ten Hagen TL
    Anticancer Res; 2004; 24(4):2243-8. PubMed ID: 15330168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells.
    Schluesener HJ; Seid K; Zhao Y; Meyermann R
    Glia; 1997 Aug; 20(4):365-72. PubMed ID: 9262239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV envelope protein gp120-induced apoptosis in lung microvascular endothelial cells by concerted upregulation of EMAP II and its receptor, CXCR3.
    Green LA; Yi R; Petrusca D; Wang T; Elghouche A; Gupta SK; Petrache I; Clauss M
    Am J Physiol Lung Cell Mol Physiol; 2014 Feb; 306(4):L372-82. PubMed ID: 24318111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40)).
    Wulff C; Wiegand SJ; Saunders PT; Scobie GA; Fraser HM
    Endocrinology; 2001 Jul; 142(7):3244-54. PubMed ID: 11416048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms for endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
    Li Z; Liu YH; Xue YX; Liu LB; Xie H
    J Mol Neurosci; 2012 Jun; 47(2):408-17. PubMed ID: 21969114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation.
    Chang SY; Park SG; Kim S; Kang CY
    J Biol Chem; 2002 Mar; 277(10):8388-94. PubMed ID: 11741979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis.
    Berger AC; Tang G; Alexander HR; Libutti SK
    J Immunother; 2000; 23(5):519-27. PubMed ID: 11001545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiological processes.
    van Horssen R; Eggermont AM; ten Hagen TL
    Cytokine Growth Factor Rev; 2006 Oct; 17(5):339-48. PubMed ID: 16945568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ΞΆ/PP2A-dependent signaling mechanism.
    Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
    Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spatial and temporal distribution of insulin-like growth factors I and II during development of rat lung.
    Wallen LD; Han VK
    Am J Physiol; 1994 Nov; 267(5 Pt 1):L531-42. PubMed ID: 7977764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tissue interactions mediate early events in pulmonary vasculogenesis.
    Gebb SA; Shannon JM
    Dev Dyn; 2000 Feb; 217(2):159-69. PubMed ID: 10706140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of Meth A fibrosarcoma derived EMAP II on dendritic cell migration.
    Haridas S; Bowers M; Tusano J; Mehojah J; Kirkpatrick M; Burnham DK
    Cytokine; 2008 Nov; 44(2):304-9. PubMed ID: 18951814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelial-monocyte-activating polypeptide II induces rat C6 glioma cell apoptosis via the mitochondrial pathway.
    Liu LB; Xie H; Xue YX; Liu YH; Li Z; Wang P
    Biochem Biophys Res Commun; 2015 Feb; 457(4):595-601. PubMed ID: 25600803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lesional expression of a proinflammatory and antiangiogenic cytokine EMAP II confined to endothelium and microglia/macrophages during secondary damage following experimental traumatic brain injury.
    Mueller CA; Schluesener HJ; Conrad S; Meyermann R; Schwab JM
    J Neuroimmunol; 2003 Feb; 135(1-2):1-9. PubMed ID: 12576219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kisspeptin effect on endothelial monocyte activating polypeptide II (EMAP-II)-associated lymphocyte cell death and metastases in colorectal cancer patients.
    Stathaki M; Armakolas A; Dimakakos A; Kaklamanis L; Vlachos I; Konstantoulakis MM; Zografos G; Koutsilieris M
    Mol Med; 2014 Mar; 20(1):80-92. PubMed ID: 24395571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cloning and expression of human endothelial-monocyte-activating polypeptide 2 (EMAP-2) and identification of its putative precursor.
    Tas MP; Houghton J; Jakobsen AM; Tolmachova T; Carmichael J; Murray JC
    Cytokine; 1997 Aug; 9(8):535-9. PubMed ID: 9245479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7.
    Behrensdorf HA; van de Craen M; Knies UE; Vandenabeele P; Clauss M
    FEBS Lett; 2000 Jan; 466(1):143-7. PubMed ID: 10648830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Serum levels of endothelial monocyte-activating polypeptide-II in type 2 diabetes mellitus].
    Mohyl'nyts'ka LA
    Fiziol Zh (1994); 2014; 60(1):84-90. PubMed ID: 24809179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.